DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Follow-Up Questions
DaVita Inc (DVA) の株価収益率はいくらですか？
DaVita Inc の株価収益率は 9.4504 です。
DaVita Inc のCEOは誰ですか？
Mr. Javier Rodriguez は DaVita Inc の Chief Executive Officer で、2000 から在籍しています。
DVA の株価パフォーマンスは？
DVA の現在の価格は $129.2 で、最終取引日から 0.01% increased 変動しました。
DaVita Inc の主な事業テーマや業界は？
DaVita Inc は Health Care 業界、セクターは Health Care に属しています。
